Scripps Research Opens Doors in
HIV/AIDS Research
Before there can be new cures...
Before there can be new treatments...
We must do the research.
HIV / AIDS:
Afflicts 42 million people worldwide.
More than 4 million deaths occur annually.
In the United States, 40,000 people are infected with HIV each year.
With no known cures, our scientists are dedicated to
opening new doors through basic biomedical research.
As one of the world's largest, private nonprofit biomedical research facilities, Scripps Research is opening new doors for the discovery of cures for HIV/AIDS.
Please join our efforts to find a cure for HIV/AIDS.
HIV/AIDS Advances at Scripps Research
Discovery of Antibody Leads to New Hope for AIDS Vaccine
The search for an AIDS vaccine took a step forward when Scripps Research scientists determined the structure of an antibody that can neutralize the virus. The antibody, called 2G12, binds to HIV and prevents it from infecting human cells. This discovery of 2G12 provides Scripps Research with the opportunity to find a drug that stops HIV before it infects the body.
A Vaccine Factory Inside Each Cell
Scientists at Scripps Research are focusing on the development and testing for a new gene delivery technique to provide protection against HIV infections. The technique involves giving patients stem cell genes that develop into platelets and red blood cells within the body and are eventually injected back into the tissue - which then grows to resist HIV infection.
Inhibitor: A Possible Weapon for Fighting HIV Proteases?
The HIV virus makes an average of one mistake every time it replicates. And because it replicates so much in an infected host, mutant HIV variants quickly arise. This has made it incredibly difficult for scientists to develop drugs to fight the HIV infection. Scripps Research professor Chi-Huey Wong has developed a new protease inhibitor that is effective against mutating strains of the AIDS virus which are resistant to current drugs.
FightAIDS@Home, run by Scripps Research, is the first biomedical distributed computing project ever launched. Its free software is installed on volunteer computers and uses their idle cycles to assist fundamental research in discovering new drugs and studying the structural biology of AIDS. This research, assisted by home and corporate computers, helps create, test, refine, and share the tools and protocols that thousands of other labs use in their research against the disease.
About Scripps Research
Scripps Research is one of the world's largest, private nonprofit biomedical research facilities. Our scientists include three Nobel Laureates, 19 members of the National Academy of Sciences, 270 faculty and scientific staff, 700 postdoctoral fellows, and 1,500 technical and support personnel. Our level of biomedical investigation is magnifying the likelihood of discovering new treatments and cures for diseases such as HIV/AIDS.
Over two million people have already benefited from medicine initially researched, developed, and tested at Scripps Research. We are committed to our pioneering medical research - research that might one day transform a disease like HIV/AIDS into a thing of the past - but we need your help!
We at Scripps Research are proud of the way we manage our funds. We are a 501(c)3 nonprofit; to learn more about our finances, please view them online or call us at 858-784-2037!
Your generosity is critical in advancing the research that will make a difference for all mankind.
Join our email list to receive periodic updates on our work and our monthly e-Newsletter, At the Forefront.
